The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Andrew Pope, Ph.D., is director of the Board on Health Sciences Policy at the IOM. He has a Ph.D. in Physiology and Biochemistry from the University of Maryland and has been a member of The National Academies staff since 1982 and of the IOM staff since 1989. His primary interests are science policy, biomedical ethics, and environmental and occupational influences on human health. During his tenure at The National Academies, Dr. Pope has directed numerous studies on topics that range from injury control, disability prevention, and biologic markers to the protection of human subjects of research, NIH priority-setting processes, organ procurement and transplantation policy, and the role of science and technology in countering terrorism. Dr. Pope is the recipient of the IOM’s Cecil Award and the National Academy of Sciences President’s Special Achievement Award.